Potential low-density lipoprotein cholesterol, cardiovascular risk and costs reduction with evolocumab: a simulation in patients with a recent myocardial infarction in Spain

Authors: C Escobar-Cervantes, M Fernandez-Delgado, C Roldan, A Sicras-Mainar, G Villa

Published: 2021-10-20

DOI: 10.1093/eurheartj/ehab724.2592

Source: Full article